Last reviewed · How we verify
ginkgolide
At a glance
| Generic name | ginkgolide |
|---|---|
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects (PHASE1)
- Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
- Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD (PHASE4)
- A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke. (PHASE2)
- The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke (PHASE2, PHASE3)
- Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial (PHASE4)
- Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke (NA)
- Cognitive and Blood Flow Effects of Mountain Tea (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |